Effects of λ-carrageenan on in vitro replication of feline herpesvirus and on experimentally induced herpetic conjunctivitis in cats

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 4, 2008, Pages 1496-1501

  Stiles, Jean ^a   Guptill Yoran, Lynn ^a   E Moore, George ^a   Ogranichniy, Roman M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; HERPES VACCINE; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CAT; CONTROLLED STUDY; EYE EXAMINATION; FEMALE; HERPES; HERPES VIRUS; IC 50; IN VITRO STUDY; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; VACCINATION; VIRAL CONJUNCTIVITIS; VIRUS ATTACHMENT; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; ANIMAL DISEASE; CAT DISEASE; CYTOTOXICITY; DNA REPLICATION; DRUG EFFECT; GERMFREE ANIMAL; HERPES VIRUS INFECTION; ISOLATION AND PURIFICATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; VIROLOGY;

ALPHAHERPESVIRINAE; ANIMALS; CARRAGEENAN; CAT DISEASES; CATS; CONJUNCTIVITIS, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; DNA REPLICATION; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; MALE; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRUS REPLICATION;

EID: 45549100396     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.07-1245     Document Type: Article

References (46)

1. Witvrouw M, Este JA, Mateu MQ, et al. Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella ten- era against human immunodeficiency virus and other enveloped viruses. Antiviral Chem Chemother. 1994;5:297-303.
2. Baba M, Snoeck R, Pauwels R, De Clercq E. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother. 1988;32:1742-1745.
3. Witvrouw M, De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol. 1997;29: 497-511.
4. Caceres PJ, Carlucci MJ, Damonte EB, Matsuhiro B, Zuniga EA. Carrageenans from Chilean samples of Stenogramme interrupta (Phyllophoraceae): structural analysis and biological activity. Phy- tochemistry. 2000;53:81-86.
5. Huleihel M, Ishanu V, Tal J, Arad SM. Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses. J Appl Phycol. 2001;13:127-134.
6. Hudson JB, Kim JH Lee K, DeWreede RE, Hong YK. Antiviral compounds in extracts of Korean seaweeds: evidence for multiple activities. J Appl Phycol. 1999;10:427- 434.
7. Hoshino T, Hayashi T, Hayashi K, Hamada J, Lee JB, Sankawa U. An antivirally active sulfated polysaccharide from Sargassum horneri (Turner) C. Agardh. Biol Pharm Bull. 1998;21:730-734.
8. Ehresmann DW, Deig EF, Hatch MT, DiSalvo LH, Vedros NA. Antiviral substances from California marine algae. JPhycol. 1977; 13:37- 40.
9. Carlucci MJ, Scolaro LA, Damonte EB. Inhibitory action of natural carrageenans on herpes simplex virus infection of mouse astro- cytes. Exp Chemother. 1999;45:429-436.
10. Serkedjieva J. Antiherpes virus effect of the red marine alga Poly- siphonia denudata. Z Naturforsch. 2000;55:830-835.
11. Kim JH, Hudson JB, Huang AM, et al. Biological activities of seaweed extracts from British Columbia, Canada and Korea, I: antiviral activity. Can J Bot. 1997;75:1656-1660.
12. Preeprame S, Hayashi K, Lee JB, Sankawa U, Hayashi T. A novel antivirally active fucan sulfate derived from an edible brown alga, Sargassum horneri. Chem Pharm Bull. 2001;49:484-485.
13. Ohta S, Ono F, Shiomi Y, et al. Anti-herpes simplex virus substances produced by the marine green alga Dunaliella primolecta. J Appl Phycol. 1998;10:349 -355.
14. Hayashi K, Hamada J, Hayashi T. A screening strategy for selection of anti-HSV-1 and anti-HIV extracts from algae. Phytother Res. 1996;10:233-237.
15. Feldman SC, Reynaldi S, Stortz CA Cerezo AS, Damonte EB. Antiviral properties of fucoidan fractions from Leathesia difformis. Phytomedicine. 1999;6:335-340.
16. Carlucci MJ, Scolaro LA, Errea MI, Matulewicz MC, Damonte EB. Antiviral activity of natural sulphated galactans on herpes virus multiplication in cell culture. Plant Medica. 1997;63:429-432.
17. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J, De Clercq E. Mechanisms of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA. 1988;85:6132-6136.
18. Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS, Damonte EB. Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antiviral Res. 1999;43:93-102.
19. Stiles J. Feline herpesvirus. Vet Clin North Am Small Anim Pract. 2000;30:1001-1014.
20. Scott FW, Geissinger CM. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res. 1999;60:652- 658.
21. Stiles J, Townsend WM, Rogers QR Krohne SG. Effect of oral administration of L-lysine on conjunctivitis caused by feline her- pesvirus in cats. Am J Vet Res. 2002;63:99-103.
22. Gray JJ. Assays for virus infection. In: Cann AJ, ed. Virus Culture: A Practical Approach. New York: Oxford University Press; 2002: 81-108.
23. Vogtlin A, Fraefel C, Albini S, et al. Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time PCR. J Clin Microbiol. 2002;40:519 -523.
24. Mishell BB, Shiigi SM. Selected Methods in Cellular Immunology. New York: WH Freeman and Company; 1980:16-17.
25. Nasisse MP, Guy JS, Davidson MG, et al. Experimental ocular herpesvirus infection in the cat: sites of virus replication, clinical features and effects of corticosteroid administration. Invest Oph- thalmol Vis Sci. 1989;30:1758-1768.
26. Roizman B, Sears AE. Herpes simplex viruses and their replication. In: Knipe DM, Howley PM, eds. Fundamental Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:1123-1184.
27. Herold B, WuDunn D, Soltys N, Spear PG. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol. 1991;65:1090 -1098.
28. Shieh M, WuDunn D, Montgomery R, Esko JD, Spear PG. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. Cell Biol. 1992;116:1273-1281.
29. Tal-Singer R, Peng C, Ponce de Leon M, et al. Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. Virol. 1995;69:4471- 4483.
30. Trybala E, Bergstrom T, Svennerholm B, Jeansson S, Glorioso JC, Olofsson S. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulfate. Gen Virol. 1994;75:743-752.
31. Sussman MD, Maes RK, Kruger JM, et al. A feline herpesvirus-1 recombinant with deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis. Virology. 1995; 214:12-20.
32. Willemse MJ, Chalmers WS, Sondermeijer PJ. In vitro properties of a feline herpesvirus type 1 mutant carrying a lacZ insertion at the gI locus of the unique short segment. Vaccine. 1996;14:1-5.
33. Maeda K, Horimoto T, Mikami T. Properties and functions of feline herpesvirus type 1 glycoproteins. J Vet Med Sci. 1998;60:881-888.
34. Pujol CA, Matulewicz MC, Cerezo AS, Damonte EB. Inhibitory action of an algal derived xylomannan on glycoprotein C-mediated biological properties of herpes simplex virus. Phytomedicine. 1998;5:205-208.
35. Pujol CA, Errea MI, Matulewicz MC, Cerezo AS, Damonte EB. Antiherpetic activity of S1, an algal derived sulphated galactan. Phytother Res. 1996;10:410-413.
36. Duarte MER, Noseda DG, Tulio S, Pujol CA, Damonte EB. Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phyto-medicine. 2001;8:53-58.
37. Damonte E, Neyts J, Pujol CA, et al. Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigiata. Bio- chem Pharmacol. 1994;47:2187-2192.
38. Nyberg K, Ekblad M, Bergstrom T, et al. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res. 2004;63:15-24.
39. Zacharopoulos VR, Phillips DM. Vaginal formulations of carra- geenan protect mice from herpes simplex virus infection. Clin Diagn Lab Immunol. 1997;4:465- 468.
40. Bourne KZ, Bourne N Reising SF, Stanberry LR. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Res. 1999; 42:219-226.
41. Damonte EB, Matulewicz MC, Cerezo AS. Sulfated seaweed poly- saccharides as antiviral agents. Curr Medicinal Chem. 2004;11: 2399-2419.
42. Flexner C, Barditch-Crovo PA, Kornhauser DM., et al. Pharmaco- kinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrob Agents Che-mother. 1991;35:2544-2550.
43. Baba M, DeClercq E, Schols D, et al. Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. J Infect Dis. 1990;161:208- 213.
44. Carlucci MJ, Pujol CA, Ciancia M, et al. Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. Int JBiol Macromol. 1997;20:97- 105.
45. Oka T, Shearer TR, Azuma M. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res. 2004;29:27-34.
46. Bonferoni MC, Chetoni P, Giunchedi P, et al. Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies. Eur J Pharma- ceut Biopharmaceut. 2004;57:465- 472.